Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions.
暂无分享,去创建一个
[1] B. Westerink,et al. Brain microdialysis and its application for the study of animal behaviour , 1995, Behavioural Brain Research.
[2] M. Sar,et al. A topographic localization of enkephalin on the dopamine neurons of the rat substantia nigra and ventral tegmental area demonstrated by combined histofluorescence-immunocytochemistry , 1980, Brain Research.
[3] H. Akil,et al. Endogenous opioids: overview and current issues. , 1998, Drug and alcohol dependence.
[4] P. Kalivas,et al. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[5] M. Fournié-Zaluski,et al. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. , 1993, Pharmacological reviews.
[6] G. Koob,et al. Methylnaloxonium diffuses out of the rat brain more slowly than naloxone after direct intracerebral injection , 1991, Neuroscience Letters.
[7] N. Koshikawa,et al. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors , 1999, Neuroscience.
[8] R. Spanagel,et al. The Effects of Opioid Peptides on Dopamine Release in the Nucleus Accumbens: An In Vivo Microdialysis Study , 1990, Journal of neurochemistry.
[9] J. B. Justice,et al. Differential Effects of δ‐ and μ‐Opioid Receptor Antagonists on the Amphetamine‐Induced Increase in Extracellular Dopamine in Striatum and Nucleus Accumbens , 1996 .
[10] J. Schwartz,et al. High-affinity enkephalin-degrading peptidase in brain is increased after morphine , 1978, Nature.
[11] G. Koob. Drugs of abuse: anatomy, pharmacology and function of reward pathways. , 1992, Trends in pharmacological sciences.
[12] F E Bloom,et al. Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. , 1978, Annual review of neuroscience.
[13] J. Schwartz,et al. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice , 1980, Nature.
[14] N. Mercuri,et al. Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[15] J. B. Justice,et al. Naloxone reduces the neurochemical and behavioral effects of amphetamine but not those of cocaine. , 1995, European journal of pharmacology.
[16] S. Holtzman,et al. Effects of naloxone and diprenorphine on amphetamine-stimulated behavior in guinea pigs and rats , 1987, Neuropharmacology.
[17] G. Koob,et al. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. , 1992, The Journal of pharmacology and experimental therapeutics.
[18] S. Holtzman. Comparison of the effects of morphine, pentazocine, cyclazocine and amphetamine on intracranial self-stimulation in the rat , 1976, Psychopharmacologia.
[19] G. Di Chiara,et al. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. , 1988, The Journal of pharmacology and experimental therapeutics.
[20] P. Deviche. Affinity of naloxone and its quaternary analogue for avian central δ and μ opioid receptors , 1997, Brain Research.
[21] H. Akil,et al. The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. , 1995, Brain research.
[22] R. Wise,et al. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. , 1993, The Journal of pharmacology and experimental therapeutics.
[23] L. Parsons,et al. Serotonin and Dopamine Sensitization in the Nucleus Accumbens, Ventral Tegmental Area, and Dorsal Raphe Nucleus Following Repeated Cocaine Administration , 1993, Journal of neurochemistry.
[24] S. Holtzman. Behavioral effects of separate and combined administration of naloxone and d-amphetamine. , 1974, The Journal of pharmacology and experimental therapeutics.
[25] P. Molinoff,et al. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine. , 1977, The Journal of pharmacology and experimental therapeutics.
[26] J. B. Justice,et al. Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens , 1992, Pharmacology Biochemistry and Behavior.
[27] G. Cohen,et al. Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. , 1975, Biochemical pharmacology.
[28] J. Schwartz,et al. Enkephalin receptors on dopaminergic neurones in rat striatum , 1977, Nature.
[29] N. Maidment,et al. Presynaptic Versus Postsynaptic Localization of μ and δ Opioid Receptors in Dorsal and Ventral Striatopallidal Pathways , 1997, The Journal of Neuroscience.
[30] L. Pellegrino,et al. stereotaxic atlas of the rat brain , 1967 .
[31] B. Westerink,et al. The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis , 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.
[32] H. Fibiger,et al. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis , 1990, Synapse.
[33] H. Akil,et al. The cloned μ, δ and κ receptors and their endogenous ligands: Evidence for two opioid peptide recognition cores , 1995, Brain Research.
[34] J. Schwartz,et al. Localization of opiate receptors in substantia nigra evidence by lesion studies , 1979, Neuroscience Letters.
[35] V. Pickel,et al. Localization of the δ‐opioid receptor and dopamine transporter in the nucleus accumbens shell: Implications for opiate and psychostimulant cross‐sensitization , 1999, Synapse.
[36] R. North,et al. Opioids excite dopamine neurons by hyperpolarization of local interneurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[37] W. Bowen,et al. Delta-opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine. , 1993, European journal of pharmacology.
[38] D. Segal,et al. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.